NCT02559492 - Itacitinib Combined With INCB024360 and/or Itacitinib Combined With INCB050465 in Advanced Solid Tumors | Biotech Hunter

Enrollment

142

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

September 10, 2018

Study Completion Date

August 18, 2019

Conditions

Solid Tumors

Interventions

DRUG

Itacitinib

Itacitinib (INCB039110) tablets will be administered orally once daily in the morning.

DRUG

Epacadostat

Epacadostat tablets will be administered orally, twice daily.

DRUG

Itacitinib

Itacitinib (INCB039110) tablets will be administered orally once daily in the morning.

DRUG

INCB050465

INCB050465 tablets will be administered orally once daily.

Trial Locations (11)

Duarte

Denver

New Haven

Tampa

Chicago

Rochester

Huntersville

Nashville

Dallas

Houston

Salt Lake City